Fatty liver disease, now medically known as MASLD, is becoming more common, especially among people who are overweight, ...

Metabolic dysfunction-associated steatohepatitis (MASH) represents a serious form of fatty liver disease that can lead to permanent damage while producing few noticeable symptoms.

T he Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week. The pill, called ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects ...

An estimated 1.5% to 6.5% of U.S. adults have MASH. afflicted by the condition, and roughly 24% of adults have metabolic dysfunction-associated steatotic fatty liver disease, the starting point ...

The dire current reality Nearly 1 in 4 Americans suffer from metabolic dysfunction–associated steatotic liver disease. Of that population, 20% have the more advanced disease form, MASH.

Conditions That Can Lead to MASLD and MASH Several metabolic problems from high blood pressure to excess body fat can lead to fatty liver disease. But those aren't the only causes. Lesson 3 of 6 ...